Novikov, P I <br/><br/>
[Experience with rituximab treatment (monoclonal antibodies to B-lymphocyte CD20 receptors) of Wegener's granulomatosis patients with renal impairment].  [electronic resource] 

 -  Terapevticheskii arkhiv  2011 
 - 70-6 p.  digital 
<br/><br/> Publication Type: English Abstract; Journal Article 
<br/><br/><label>ISSN: </label>0040-3660 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antibodies, Monoclonal, Murine-Derived--adverse effects<br/>Antigens, CD20--immunology<br/>B-Lymphocytes--immunology<br/>Dose-Response Relationship, Drug<br/>Female<br/>Glucocorticoids--administration & dosage<br/>Granulomatosis with Polyangiitis--drug therapy<br/>Humans<br/>Immunologic Factors--adverse effects<br/>Kidney Diseases--drug therapy<br/>Male<br/>Middle Aged<br/>Prednisolone--administration & dosage<br/>Recurrence<br/>Remission Induction--methods<br/>Rituximab<br/>Treatment Outcome<br/>Young Adult